Electromed, Inc.(ELMD)Earnings, Financials & Key Ratios

ELMD•AMEX

$25.94

$215M mkt cap·30.2× P/E·Price updated May 6, 2026

SectorHealthcare IndustryMedical Devices Sub-IndustryRespiratory and sleep therapy devices

AboutElectromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was incorporated in 1992 and is headquartered in New Prague, Minnesota.Show more

Revenue$64M+17.0%
EBITDA$11M+45.9%
Net Income$8M+46.3%
EPS (Diluted)0.86+48.3%
Gross Margin78.08%+2.4%
EBITDA Margin16.93%+24.8%
Operating Margin15.09%+25.5%
Net Margin11.78%+25.1%
ROE17.18%+37.1%
ROIC25.57%+52.8%
Debt/Equity0.00+134.6%

Technical→

ELMD Key Insights

Electromed, Inc. (ELMD) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Company is almost debt free
✓Strong Piotroski F-Score: 7/9
✓FCF machine: 17.3% free cash flow margin
✓High quality earnings: Operating CF exceeds net income
✓Strong 5Y sales CAGR of 14.5%
✓Efficient asset utilization: 1.2x turnover

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

ELMD Price & Volume

Electromed, Inc. (ELMD) stock price & volume — 10-year historical chart

Loading chart...

ELMD Growth Metrics

Electromed, Inc. (ELMD) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years12.67%

5 Years14.53%

3 Years15.39%

TTM15.49%

Profit CAGR

10 Years21.3%

5 Years12.62%

3 Years48.43%

TTM32.96%

EPS CAGR

10 Years20.8%

5 Years12.84%

3 Years49%

TTM37.33%

Return on Capital

10 Years14.91%

5 Years13.61%

3 Years16.37%

Last Year21.98%

ELMD Recent Earnings

Electromed, Inc. (ELMD) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 10/12 qtrs (83%)●Beat Revenue 6/12 qtrs (50%)

Q1 2026Latest

Feb 10, 2026

EPS

$0.32

Est $0.27

+18.5%

Revenue

$19M

Est $18M

+4.7%

Q4 2025

Nov 12, 2025

EPS

$0.25

Est $0.22

+13.6%

Revenue

$17M

Est $18M

-7.7%

Q3 2025

Aug 26, 2025

EPS

$0.25

Est $0.22

+13.6%

Revenue

$17M

Est $16M

+6.4%

Q2 2025

May 13, 2025

EPS

$0.21

Est $0.20

+5.0%

Revenue

$16M

Est $17M

-5.8%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q1 2026Latest	Feb 10, 2026	$0.32vs $0.27+18.5%	$19Mvs $18M+4.7%
Q4 2025	Nov 12, 2025	$0.25vs $0.22+13.6%	$17Mvs $18M-7.7%
Q3 2025	Aug 26, 2025	$0.25vs $0.22+13.6%	$17Mvs $16M+6.4%
Q2 2025	May 13, 2025	$0.21vs $0.20+5.0%	$16Mvs $17M-5.8%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	Debt / Equity
INGNInogen, Inc.Direct Competitor	193.03M	7.11	-8.36	3.86%	-6.52%	-11.83%	0.09
LNTHLantheus Holdings, Inc.Product Competitor	5.61B	86.15	25.26	0.5%	15.15%	20.58%	0.00
LUNGPulmonx CorporationProduct Competitor	54.49M	1.29	-0.97	8.01%	-59.67%	-82.79%	1.04
SPXCSPX Technologies, Inc.Product Competitor	10.67B	212.74	42.04	14.17%	10.8%	12.37%	0.22
ABTAbbott LaboratoriesSupply Chain	149.97B	86.25	11.29	4.59%	31.88%	27.26%	0.32
MDTMedtronic plcSupply Chain	99.48B	77.60	21.50	3.62%	13%	9.45%	0.59
PHGKoninklijke Philips N.V.Supply Chain	25.9B	27.23	24.95	-1.04%	5.02%	8.19%	0.74
HOLXHologic, Inc.Supply Chain	16.97B	76.01	30.53	1.74%	13.18%	10.37%	0.52

Compare ELMD vs Peers

Electromed, Inc. (ELMD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs INGN

Most directly comparable listed peer for ELMD.

Scale Benchmark

vs ABT

Larger-name benchmark to compare ELMD against a more recognizable public peer.

Peer Set

Compare Top 5

vs INGN, LNTH, LUNG, SPXC

ELMD Income Statement

Electromed, Inc. (ELMD) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Jun'17	Jun'18	Jun'19	Jun'20	Jun'21	Jun'22	Jun'23	Jun'24	Jun'25	TTM
Sales/Revenue	25.86M	28.31M	31.3M	32.47M	35.76M	41.66M	48.07M	54.72M	64M	68.86M
Revenue Growth %	12.48%	9.46%	10.57%	3.74%	10.12%	16.51%	15.38%	13.83%	16.97%	15.49%
Cost of Goods Sold	5.29M	6.53M	7.45M	7.27M	8.45M	10.22M	11.55M	12.99M	14.03M	14.99M
COGS % of Revenue	20.47%	23.08%	23.81%	22.39%	23.64%	24.53%	24.02%	23.74%	21.92%	-
Gross Profit	20.57M▲ 0%	21.77M▲ 5.9%	23.85M▲ 9.5%	25.2M▲ 5.7%	27.3M▲ 8.4%	31.44M▲ 15.2%	36.52M▲ 16.1%	41.73M▲ 14.3%	49.97M▲ 19.8%	53.87M▲ 0%
Gross Margin %	79.53%	76.92%	76.19%	77.61%	76.36%	75.47%	75.98%	76.26%	78.08%	78.23%
Gross Profit Growth %	15.06%	5.85%	9.53%	5.67%	8.35%	15.15%	16.15%	14.26%	19.76%	-
Operating Expenses	17M	19.06M	21.02M	20.08M	24.16M	28.47M	32.51M	35.15M	40.31M	42.4M
OpEx % of Revenue	65.73%	67.33%	67.15%	61.85%	67.58%	68.34%	67.64%	64.23%	62.99%	-
Selling, General & Admin	16.4M	18.81M	20.44M	19.95M	22.44M	27.11M	31.59M	34.49M	39.31M	41.2M
SG&A % of Revenue	63.42%	66.45%	65.29%	61.42%	62.77%	65.09%	65.73%	63.03%	61.43%	-
Research & Development	596.88K	251.44K	583.31K	1.05M	1.72M	1.36M	916K	656K	996K	1.2M
R&D % of Revenue	2.31%	0.89%	1.86%	3.23%	4.82%	3.26%	1.91%	1.2%	1.56%	-
Other Operating Expenses	0	0	0	-913K	0	0	0	0	0	0
Operating Income	3.57M▲ 0%	2.71M▼ 24.0%	2.83M▲ 4.3%	5.12M▲ 80.9%	3.14M▼ 38.6%	2.97M▼ 5.4%	4.01M▲ 34.9%	6.58M▲ 64.2%	9.66M▲ 46.8%	11.47M▲ 0%
Operating Margin %	13.8%	9.58%	9.04%	15.76%	8.78%	7.13%	8.34%	12.03%	15.09%	16.66%
Operating Income Growth %	14.8%	-24.01%	4.33%	80.87%	-38.65%	-5.35%	34.86%	64.2%	46.79%	-
EBITDA	4.32M	3.5M	3.75M	5.86M	3.75M	3.6M	4.62M	7.42M	10.83M	12.36M
EBITDA Margin %	16.72%	12.37%	12%	18.04%	10.49%	8.64%	9.61%	13.56%	16.93%	17.95%
EBITDA Growth %	12.38%	-19.01%	7.21%	56.04%	-36%	-4%	28.36%	60.61%	45.94%	29.25%
D&A (Non-Cash Add-back)	755.13K	790.03K	925.23K	741K	610K	628K	613K	841K	1.17M	894K
EBIT	3.57M	2.71M	2.83M	5.12M	3.14M	2.97M	4.01M	6.58M	9.66M	7.98M
Net Interest Income	-49.87K	19.87K	90.71K	121K	39K	25K	78K	455K	624K	411K
Interest Income	17.04K	19.87K	90.71K	120.75K	39K	25K	78K	455K	624K	411K
Interest Expense	66.91K	0	0	0	0	0	0	0	0	0
Other Income/Expense	-49.87K	19.87K	90.71K	121K	27K	25K	78K	455K	624K	520K
Pretax Income	3.52M▲ 0%	2.73M▼ 22.4%	2.92M▲ 6.9%	5.24M▲ 79.4%	3.17M▼ 39.5%	3M▼ 5.4%	4.09M▲ 36.3%	7.04M▲ 72.2%	10.28M▲ 46.2%	11.99M▲ 0%
Pretax Margin %	13.61%	9.65%	9.33%	16.13%	8.86%	7.19%	8.5%	12.86%	16.07%	17.41%
Income Tax	1.29M	901K	940K	1.08M	805K	692K	920K	1.89M	2.75M	3M
Effective Tax Rate %	36.65%	32.98%	32.19%	20.58%	25.42%	23.09%	22.52%	26.81%	26.71%	25%
Net Income	2.23M▲ 0%	1.83M▼ 17.9%	1.98M▲ 8.1%	4.16M▲ 110.1%	2.36M▼ 43.2%	2.31M▼ 2.4%	3.17M▲ 37.4%	5.15M▲ 62.7%	7.54M▲ 46.3%	8.99M▲ 0%
Net Margin %	8.62%	6.47%	6.33%	12.81%	6.61%	5.53%	6.59%	9.41%	11.78%	13.06%
Net Income Growth %	0.77%	-17.87%	8.15%	110.12%	-43.23%	-2.41%	37.35%	62.67%	46.35%	32.96%
Net Income (Continuing)	2.23M	1.83M	1.98M	4.16M	2.36M	2.31M	3.17M	5.15M	7.54M	6.23M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	0.26▲ 0%	0.22▼ 15.4%	0.23▲ 4.5%	0.47▲ 104.3%	0.27▼ 42.6%	0.26▼ 3.7%	0.36▲ 38.5%	0.58▲ 61.1%	0.86▲ 48.3%	1.03▲ 0%
EPS Growth %	-3.7%	-15.38%	4.55%	104.35%	-42.55%	-3.7%	38.46%	61.11%	48.28%	37.33%
EPS (Basic)	0.27	0.23	0.24	0.50	0.28	0.27	0.37	0.60	0.90	-
Diluted Shares Outstanding	8.46M	8.62M	8.63M	8.83M	8.91M	8.77M	8.7M	8.86M	8.72M	8.69M
Basic Shares Outstanding	8.17M	8.21M	8.31M	8.4M	8.57M	8.47M	8.46M	8.56M	8.33M	8.27M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

ELMD Balance Sheet

Electromed, Inc. (ELMD) balance sheet — assets, liabilities & shareholders' equity

Line item	Jun'17	Jun'18	Jun'19	Jun'20	Jun'21	Jun'22	Jun'23	Jun'24	Jun'25	TTM
Total Current Assets	18.48M	22.21M	24.54M	28.02M	31.7M	34.54M	37.79M	44.17M	45.08M	45.57M
Cash & Short-Term Investments	5.57M	7.46M	7.81M	10.48M	11.89M	8.15M	7.37M	16.08M	15.29M	13.79M
Cash Only	5.57M	7.46M	7.81M	10.48M	11.89M	8.15M	7.37M	16.08M	15.29M	13.79M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	9.95M	12.59M	13.76M	13.84M	17.43M	21.34M	24.62M	24.05M	25.7M	26.26M
Days Sales Outstanding	140.43	162.31	160.41	155.62	177.88	186.96	186.93	160.45	146.55	136.99
Inventory	2.56M	2.36M	2.62M	3.08M	2.11M	3.18M	4.22M	3.71M	3.3M	3.46M
Days Inventory Outstanding	176.51	131.87	128.43	154.87	91.3	113.53	133.41	104.3	85.83	82.14
Other Current Assets	0	0	0	262K	0	0	1.58M	1	408K	2.06M
Total Non-Current Assets	4.58M	4.43M	4.82M	5.22M	5.41M	6.83M	8.02M	8.06M	8.72M	9.34M
Property, Plant & Equipment	3.3M	3.09M	3.6M	3.87M	3.69M	4.69M	5.67M	5.25M	4.91M	5.22M
Fixed Asset Turnover	7.83x	9.16x	8.68x	8.39x	9.68x	8.89x	8.47x	10.42x	13.03x	13.36x
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	721.28K	649.1K	581.41K	598K	663K	599K	605K	657K	1.32M	387K
Long-Term Investments	0	0	-44	0	-88K	-120M	0	0	0	0
Other Non-Current Assets	99.87K	91.91K	44	755K	88K	120M	161K	2.15M	2.48M	7.45M
Total Assets	23.06M▲ 0%	26.64M▲ 15.5%	29.35M▲ 10.2%	33.24M▲ 13.3%	37.11M▲ 11.6%	41.36M▲ 11.5%	45.81M▲ 10.7%	52.23M▲ 14.0%	53.8M▲ 3.0%	54.91M▲ 0%
Asset Turnover	1.12x	1.06x	1.07x	0.98x	0.96x	1.01x	1.05x	1.05x	1.19x	1.28x
Asset Growth %	12.01%	15.51%	10.2%	13.25%	11.62%	11.47%	10.74%	14.03%	3%	24.91%
Total Current Liabilities	2.9M	4.74M	3.62M	2.99M	4.64M	7.15M	8.05M	7.68M	10.47M	9.38M
Accounts Payable	663.38K	810.64K	586.58K	556K	685K	1.26M	1.37M	1.01M	2.67M	2.32M
Days Payables Outstanding	45.75	45.28	28.73	27.91	29.59	45.05	43.37	28.38	69.39	60.89
Short-Term Debt	50.7K	1.1M	0	0	33K	0	80K	0	0	0
Deferred Revenue (Current)	1.54M	397.39K	-30.32K	0	0	1.54M	-80K	0	0	0
Other Current Liabilities	1.24M	1.16M	1.13M	740K	940K	-203K	1.45M	1.84M	1.65M	9.38M
Current Ratio	6.38x	4.68x	6.78x	9.38x	6.83x	4.83x	4.69x	5.75x	4.31x	4.31x
Quick Ratio	5.50x	4.19x	6.05x	8.35x	6.38x	4.39x	4.17x	5.27x	3.99x	3.99x
Cash Conversion Cycle	271.19	248.9	260.11	282.57	239.59	255.44	276.98	236.37	162.99	158.25
Total Non-Current Liabilities	1.1M	0	14.74K	9K	54K	41K	86K	12K	125K	96K
Long-Term Debt	1.1M	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	0	0	14.74K	9K	54K	41K	81K	12K	125K	235K
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	0	0	0	-1	0	0	5K	0	0	206K
Total Liabilities	3.99M	4.74M	3.62M	2.99M	4.69M	7.19M	8.14M	7.69M	10.59M	9.47M
Total Debt	1.15M	1.1M	45.06K	81K	87K	41K	161K	87K	198K	0
Net Debt	-4.43M	-6.35M	-7.76M	-10.4M	-11.8M	-8.11M	-7.21M	-15.99M	-15.09M	-13.79M
Debt / Equity	0.06x	0.05x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x
Debt / EBITDA	0.27x	0.31x	0.01x	0.01x	0.02x	0.01x	0.03x	0.01x	0.02x	0.00x
Net Debt / EBITDA	-1.02x	-1.81x	-2.07x	-1.77x	-3.15x	-2.25x	-1.56x	-2.15x	-1.39x	-1.39x
Interest Coverage	53.34x	-	-	-	-	-	-	-	-	-
Total Equity	19.07M▲ 0%	21.9M▲ 14.8%	25.73M▲ 17.5%	30.25M▲ 17.5%	32.42M▲ 7.2%	34.17M▲ 5.4%	37.67M▲ 10.2%	44.55M▲ 18.3%	43.21M▼ 3.0%	45.44M▲ 0%
Equity Growth %	16.56%	14.83%	17.53%	17.55%	7.16%	5.42%	10.22%	18.26%	-3%	12.34%
Book Value per Share	2.25	2.54	2.98	3.43	3.64	3.90	4.33	5.03	4.96	5.23
Total Shareholders' Equity	19.07M	21.9M	25.73M	30.25M	32.42M	34.17M	37.67M	44.55M	43.21M	45.44M
Common Stock	82.3K	82.89K	84.08K	86K	85K	85K	86K	87K	83K	83K
Retained Earnings	4.96M	6.86M	9.52M	13.68M	14.92M	15.78M	18.79M	23.67M	21.18M	22.28M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-3.24M	-3.74M	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0

ELMD Cash Flow Statement

Electromed, Inc. (ELMD) cash flow — operating, investing & free cash flow history

Line item	Jun'17	Jun'18	Jun'19	Jun'20	Jun'21	Jun'22	Jun'23	Jun'24	Jun'25	TTM
Cash from Operations	1.19M	2.44M	2.59M	4.2M	3.08M	-686K	1.31M	9.07M	11.39M	11.39M
Operating CF Margin %	4.61%	8.63%	8.27%	12.92%	8.61%	-1.65%	2.74%	16.57%	17.8%	-
Operating CF Growth %	-45.03%	105.03%	6.05%	62.02%	-26.67%	-122.29%	291.69%	589.51%	25.65%	-57.17%
Net Income	2.23M	1.9M	1.97M	4.16M	2.36M	2.31M	3.17M	5.15M	7.54M	8.99M
Depreciation & Amortization	755.13K	790.03K	925.23K	741K	610K	628K	613K	841K	1.17M	1.11M
Stock-Based Compensation	479.48K	862.67K	924.07K	902K	1.02M	976K	708K	1.69M	3.06M	2.52M
Deferred Taxes	-117K	-134K	-265K	-126K	-294K	-489K	-43K	-571K	-310K	-310K
Other Non-Cash Items	149.09K	36.46K	17.98K	0	0	0	0	0	212K	-3.03M
Working Capital Changes	-2.31M	-1.02M	-981.63K	-1.48M	-625K	-4.11M	-3.13M	1.96M	-277K	-151K
Change in Receivables	-2.34M	-1.61M	-948.73K	-350K	-3.58M	-3.91M	-3.28M	565K	-1.64M	-2.31M
Change in Inventory	-28.33K	234.59K	-106.17K	-449K	971K	-1.07M	-1.03M	459K	175K	-585K
Change in Payables	-337.47K	555.99K	-2.56K	-472K	214K	2.17M	420K	-1.21M	1.65M	1.13M
Cash from Investing	-687.15K	-571.78K	-1.39M	-977K	-448K	-1.52M	-1.72M	-395K	-306K	-934K
Capital Expenditures	-687.15K	-571.78K	-1.39M	-844K	-287K	-1.52M	-1.72M	-395K	-306K	-11K
CapEx % of Revenue	2.66%	2.02%	4.44%	2.6%	0.8%	3.66%	3.57%	0.72%	0.48%	-
Acquisitions	0	0	1.75K	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-68.39K	-45.55K	-56.04K	-133K	-161K	0	0	0	0	-923K
Cash from Financing	-53.62K	11.71K	-851.15K	-548K	-1.22M	-1.52M	-380K	36K	-11.88M	-10.64M
Debt Issued (Net)	-48.75K	-50.7K	-1.1M	0	0	0	0	0	0	0
Equity Issued (Net)	0	0	0	0	-1000K	-1000K	-153K	-275K	-1000K	-3M
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	-1.12M	-1.45M	-153K	-275K	-10M	-9.23M
Other Financing	-4.87K	62.41K	251.85K	-548K	-95K	-77K	-227K	311K	-1.88M	-4.21M
Net Change in Cash	450.35K▲ 0%	1.88M▲ 317.9%	352.08K▼ 81.3%	2.67M▲ 658.6%	1.41M▼ 47.2%	-3.74M▼ 365.0%	-781K▲ 79.1%	8.71M▲ 1215.0%	-793K▼ 109.1%	-2.44M▲ 0%
Free Cash Flow	503.97K▲ 0%	1.87M▲ 271.1%	1.2M▼ 35.8%	3.22M▲ 167.9%	2.63M▼ 18.3%	-2.21M▼ 184.1%	-401K▲ 81.9%	8.67M▲ 2262.6%	11.09M▲ 27.8%	9.21M▲ 0%
FCF Margin %	1.95%	6.61%	3.84%	9.91%	7.35%	-5.31%	-0.83%	15.85%	17.32%	13.37%
FCF Growth %	-68.29%	271.14%	-35.76%	167.92%	-18.33%	-184.1%	81.86%	2262.59%	27.85%	-15.52%
FCF per Share	0.06	0.22	0.14	0.36	0.30	-0.25	-0.05	0.98	1.27	1.27
FCF Conversion (FCF/Net Income)	0.53x	1.33x	1.31x	1.01x	1.30x	-0.30x	0.42x	1.76x	1.51x	1.02x
Interest Paid	59.23K	46K	22.99K	3.13K	0	0	0	0	0	0
Taxes Paid	1.09M	1.02M	1.31M	1.75M	534K	1.42M	676K	2.51M	3.74M	2.03M

ELMD Key Ratios

Electromed, Inc. (ELMD) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025	TTM
Return on Equity (ROE)	12.59%	8.94%	8.32%	14.87%	7.54%	6.92%	8.81%	12.53%	17.18%	19.79%
Return on Invested Capital (ROIC)	19.77%	13.48%	12.67%	20.3%	11.64%	9.55%	10.64%	16.73%	25.57%	25.57%
Gross Margin	79.53%	76.92%	76.19%	77.61%	76.36%	75.47%	75.98%	76.26%	78.08%	78.23%
Net Margin	8.62%	6.47%	6.33%	12.81%	6.61%	5.53%	6.59%	9.41%	11.78%	13.06%
Debt / Equity	0.06x	0.05x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x
Interest Coverage	53.34x	-	-	-	-	-	-	-	-	-
FCF Conversion	0.53x	1.33x	1.31x	1.01x	1.30x	-0.30x	0.42x	1.76x	1.51x	1.02x
Revenue Growth	12.48%	9.46%	10.57%	3.74%	10.12%	16.51%	15.38%	13.83%	16.97%	15.49%

ELMD SEC Filings & Documents

Electromed, Inc. (ELMD) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

Feb 10, 2026·SEC

Material company update

Dec 18, 2025·SEC

Material company update

Nov 18, 2025·SEC

10-K Annual Reports

FY 2025

Aug 26, 2025·SEC

FY 2024

Aug 27, 2024·SEC

FY 2023

Aug 22, 2023·SEC

10-Q Quarterly Reports

FY 2026

Feb 10, 2026·SEC

FY 2025

Nov 12, 2025·SEC

FY 2025

May 13, 2025·SEC

ELMD Frequently Asked Questions

Electromed, Inc. (ELMD) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Electromed, Inc. (ELMD) reported $68.9M in revenue for fiscal year 2025. This represents a 687% increase from $8.8M in 2008.

Electromed, Inc. (ELMD) grew revenue by 17.0% over the past year. This is strong growth.

Yes, Electromed, Inc. (ELMD) is profitable, generating $9.0M in net income for fiscal year 2025 (11.8% net margin).

Dividend & Returns

Electromed, Inc. (ELMD) has a return on equity (ROE) of 17.2%. This is reasonable for most industries.

Electromed, Inc. (ELMD) generated $9.2M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More ELMD

Electromed, Inc. (ELMD) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Electromed, Inc.(ELMD)Earnings, Financials & Key Ratios

ELMD Key Insights

✓Strengths

✗Weaknesses

ELMD Price & Volume

ELMD Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

ELMD Recent Earnings

ELMD Peer Comparison

Compare ELMD vs Peers

vs INGN

vs ABT

Compare Top 5

ELMD Income Statement

ELMD Balance Sheet

ELMD Cash Flow Statement

ELMD Key Ratios

ELMD SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

ELMD Frequently Asked Questions

Explore More ELMD

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation